Mohammed Kashani‐Sabet

Author

University of California, San Francisco

Also Known As

M Kashani-Sabet, M. Kashani-Sabet, MOHAMMED KASHANI‐SABET, Mohammed Kashani-Sabet, Mohammed Kashani‐Sabet

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco City Of Hope National Medical Center University of California San Francisco Medical Center Kitasato University

About

Mohammed Kashani‐Sabet is an author at University of California, San Francisco specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	697
2	Cell Biology	6	6	277
3	Pathology	3	3	146
4	Health Sciences	2	2	148
5	Molecular Biology	1	1	34

Mohammed Kashani‐Sabet

Publications

Citations

H-Index

Page 1

	Year	Citations
Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty-nine patients Herschel S. Zackheim, Mohammed Kashani‐Sabet, Sam T. Hwang Journal of the American Academy of Dermatology Lymphoid NeoplasiaOncologyLow-dose MethotrexateTwenty-nine PatientsDermatology	1996	152
Prediction of Sentinel Lymph Node Micrometastasis by Histological Features in Primary Cutaneous Malignant Melanoma Serena Mraz‐Gernhard, Richard W. Sagebiel, Mohammed Kashani‐Sabet, Archives of Dermatology	1998	129
Perineural spread of malignant melanoma of the head and neck: clinical and imaging features P C Chang, Nancy J. Fischbein, Timothy H. McCalmont, American Journal of Ophthalmology Skin CancerImaging FeaturesMelanomaNeck PathologyHead And Neck Cancer	2004	103
Osteopontin as a molecular prognostic marker for melanoma Javier Rangel, Mehdi Nosrati, Sima Torabian, Cancer	2007	102
Ribozyme-mediated reversal of the multidrug-resistant phenotype. Kevin J. Scanlon, Hironori Ishida, Mohammed Kashani‐Sabet Proceedings of the National Academy of Sciences Mdr GeneRibozyme-mediated ReversalPharmacotherapyAntimicrobial ChemotherapyCancer Biology	1994	90
Early experience with sentinel lymph node mapping for Merkel cell carcinoma Stanley P. L. Leong, Mohammed Kashani‐Sabet, Jan H. Wong Journal of the American Academy of Dermatology MedicineEarly ExperiencePathologyLymphatic SystemMerkel Cell Carcinoma	2001	71
Prognostic factors in patients with thick cutaneous melanoma (> 4 mm) Elizabeth Zettersten, Richard W. Sagebiel, James R. Miller, Cancer	2002	58
Fine needle aspiration in the diagnosis of metastatic melanoma Stanley P. L. Leong, Britt‐Marie Ljung, Richard W. Sagebiel, Journal of the American Academy of Dermatology Surgical OncologySkin CancerMedical ImagingMelanomaHistopathology	2000	58
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells Tomonari Suzuki, B Anderegg, Toshika Ohkawa, Gene Therapy Tumor BiologyBreast OncologyVivo GrowthMedicineBreast Cancer Cells	2000	58
Suppression of the Malignant Phenotype of Melanoma Cells by Anti-Oncogene Ribozymes Y. Ohta, Hiroshi Kijima, Mohammed Kashani‐Sabet, Journal of Investigative Dermatology Tumor BiologyMalignant DiseaseOncogenic AgentMedicineMelanoma	1996	45

Page 1